DENTSPLY SIRONA Inc. XRAY
DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") is the world's largest diversified manufacturer of professional dental products and technologies, with a 139-year history of innovation and service to the dental industry and a vision of improving oral health and continence care globally. Dentsply Sirona develops, manufactures, and markets comprehensive solutions, including technologically advanced dental equipment supported by cloud-enabled software solutions as well as dental products and healthcare consumable products in urology and enterology under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better, safer, and faster dentistry. Dentsply Sirona's worldwide headquarters is located in Charlotte, North Carolina. The Company's shares of common stock are listed in the United States on the Nasdaq stock market under the symbol XRAY.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.68B | $3.79B | $3.96B | $3.92B | $4.23B | $3.34B | $4.02B | $3.99B | $3.99B | $3.75B |
| Cost of revenue | $1.84B | $1.83B | $1.88B | $1.79B | $1.88B | $1.68B | $1.86B | $1.92B | $1.80B | $1.74B |
| Gross profit | $1.84B | $1.96B | $2.09B | $2.13B | $2.35B | $1.66B | $2.16B | $2.07B | $2.19B | $2.00B |
| R&D | $150.0M | $165.0M | $184.0M | $174.0M | $171.0M | $123.0M | $143.0M | $161.0M | $151.7M | $128.5M |
| SG&A | $1.44B | $1.60B | $1.61B | $1.59B | $1.55B | $1.30B | $1.59B | $1.72B | $1.67B | $1.52B |
| Operating income | -$422.0M | -$879.0M | -$85.0M | -$937.0M | $608.0M | -$3.0M | $353.0M | -$958.0M | -$1.56B | $454.7M |
| Interest expense | $88.0M | $69.0M | $81.0M | $65.0M | $61.0M | $48.0M | $30.0M | $37.0M | $38.3M | $35.9M |
| Pre-tax income | -$486.0M | -$936.0M | -$175.0M | -$1.05B | $545.0M | -$50.0M | $338.0M | -$958.0M | -$1.60B | $440.9M |
| Income tax | $112.0M | $26.0M | $43.0M | $105.0M | $134.0M | $23.0M | $82.0M | $53.0M | $53.2M | $9.5M |
| Net income | -$598.0M | -$910.0M | -$132.0M | -$950.0M | $411.0M | -$73.0M | $256.0M | -$1.01B | -$1.55B | $429.9M |
| EPS, basic | -3.00 | -4.48 | -0.62 | -4.41 | 1.88 | -0.33 | 1.15 | -4.51 | -6.76 | 1.97 |
| EPS, diluted | -3.00 | -4.48 | -0.62 | -4.41 | 1.87 | -0.33 | 1.14 | -4.51 | -6.76 | 1.94 |
| Shares, diluted (wtd. avg.) | $199.4M | $203.2M | $212.0M | $215.5M | $220.2M | $219.2M | $224.4M | $224.3M | $229.4M | $221.6M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $326.0M | $272.0M | $334.0M | $365.0M | $339.0M | $438.0M | $405.0M | $310.0M | $321.0M | $383.9M |
| Inventory | $642.0M | $564.0M | $624.0M | $627.0M | $515.0M | $476.0M | $562.0M | $598.9M | $623.1M | $517.1M |
| Total current assets | $2.02B | $1.75B | $1.97B | $1.89B | $1.85B | $1.80B | $2.00B | $1.89B | $2.00B | $1.74B |
| Property, plant and equipment | — | — | — | $761.0M | $773.0M | $791.0M | $802.0M | $871.0M | $876.0M | $799.8M |
| Goodwill | $1.15B | $1.60B | $2.44B | $2.69B | $3.98B | $3.99B | $3.40B | $3.43B | $4.54B | $5.95B |
| Other intangibles | $974.0M | $1.21B | $1.71B | $1.90B | $2.32B | $2.50B | $2.18B | $2.42B | $2.80B | $2.96B |
| Total assets | $5.43B | $5.75B | $7.37B | $7.64B | $9.24B | $9.35B | $8.60B | $8.69B | $10.37B | $11.56B |
| Accounts payable | $300.0M | $241.0M | $305.0M | $279.0M | $262.0M | $302.0M | $308.0M | $283.9M | $284.4M | $223.0M |
| Short-term debt | $228.0M | $128.0M | $77.0M | $1.0M | $1.0M | $296.0M | $0 | $10.6M | $9.2M | $11.0M |
| Total current liabilities | $1.34B | $1.59B | $1.43B | $1.17B | $1.26B | $1.37B | $995.0M | $1.01B | $954.5M | $767.6M |
| Long-term debt | $2.02B | $1.59B | $1.80B | $1.83B | $1.91B | $1.98B | $1.43B | $1.56B | $1.61B | $1.51B |
| Total liabilities | $4.09B | $3.81B | $4.08B | $3.83B | $4.24B | $4.42B | $3.51B | $3.55B | $3.75B | $3.43B |
| Retained earnings | -$1.56B | -$835.0M | $205.0M | $456.0M | $1.51B | $1.20B | $1.40B | $1.23B | $2.32B | $3.95B |
| Total equity | $1.34B | $1.94B | $3.29B | $3.81B | $5.00B | $4.93B | $5.05B | $5.08B | $6.63B | $8.13B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $235.0M | $461.0M | $377.0M | $517.0M | $657.0M | $649.0M | $639.0M | $500.0M | $601.9M | $563.4M |
| Depreciation and amortisation | $352.0M | $349.0M | $343.0M | $328.0M | $347.0M | $334.0M | $323.0M | $331.0M | $316.4M | $271.7M |
| Stock-based compensation | $33.0M | $39.0M | $46.0M | $59.0M | $48.0M | $47.0M | $66.0M | $21.0M | $48.0M | $41.3M |
| Capital expenditure | $131.0M | $180.0M | $149.0M | $149.0M | $142.0M | $87.0M | $123.0M | $183.0M | $144.3M | $125.0M |
| Investing cash flow | -$132.0M | -$197.0M | -$89.0M | -$138.0M | -$358.0M | -$1.11B | -$69.0M | -$253.0M | -$286.4M | $60.0M |
| Financing cash flow | -$80.0M | -$302.0M | -$307.0M | -$329.0M | -$379.0M | $476.0M | -$472.0M | -$250.0M | -$400.8M | -$526.2M |
| Dividends paid | $128.0M | $126.0M | $116.0M | $104.0M | $92.0M | $88.0M | $81.0M | $79.0M | $78.3M | $64.6M |
| Buybacks | $0 | $250.0M | $300.0M | $150.0M | $200.0M | $140.0M | $260.0M | $250.0M | $401.4M | $813.9M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000818479-26-000125.
Others in SIC 3843
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| NVST | Envista Holdings Corp | $4.38B | 97.4x | 8.3% |